|Yesterday's News, December 05, 2022|
|November 21, 2022|
|November 17, 2022|
Gritstone to Participate in Upcoming Investor Conferences(Globe Newswire)
|November 10, 2022|
|November 03, 2022|
|October 25, 2022|
Gritstone bio Announces Private Placement of $45.0 Million(Globe Newswire)
|October 19, 2022|
|October 17, 2022|
|September 20, 2022|
|September 12, 2022|
Gritstone Presents Positive Initial Phase 2 Data in Late-Line Solid Tumor Patients Treated With KRAS-Directed Immunotherapy (SLATE) at ESMO 2022
-- Molecular response, as measured by reduction in circulating tumor DNA (ctDNA) from baseline, demonstrates a correlation with overall survival (OS) in NSCLC...(Globe Newswire)
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2022. All rights reserved.